Protagonist Therapeutics, Inc. (PTGX)
103.67
-1.73
(-1.64%)
USD |
NASDAQ |
Apr 01, 16:00
103.68
+0.01
(+0.01%)
After-Hours: 20:00
Protagonist Therapeutics Research and Development Expense (TTM) : 159.29M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 14.72B |
| AbbVie, Inc. | 9.096B |
| Insmed, Inc. | 771.09M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| PTC Therapeutics, Inc. | 455.25M |